Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Polyomavirus Infections”

186 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 186 results

Testing effectiveness (Phase 2)Looking for participantsNCT05583708
What this trial is testing

Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer

Who this might be right for
Merkel Cell Carcinoma
Weill Medical College of Cornell University 18
Post-approval studies (Phase 4)Study completedNCT00160966
What this trial is testing

Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy

Who this might be right for
Polyomavirus Infections
University of Giessen 108
Not applicableLooking for participantsNCT06008977
What this trial is testing

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Who this might be right for
Cutaneous MelanomaCutaneous Squamous Cell CarcinomaMerkel Cell Carcinoma
AdventHealth Translational Research Institute 20
Testing effectiveness (Phase 2)UnknownNCT05541549
What this trial is testing

Study Evaluating JCPyV-specific T Cell Therapy for PML

Who this might be right for
Progressive Multifocal Leukoencephalopathy
Cellevolve Bio Inc 60
Early research (Phase 1)Active Not RecruitingNCT03816332
What this trial is testing

Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+18 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)UnknownNCT03544723
What this trial is testing

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

Who this might be right for
Solid TumorLymphoma
MultiVir, Inc. 40
Not applicableStudy completedNCT01526486
What this trial is testing

Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer

Who this might be right for
MelanomaMerkel Cell CarcinomaSquamous Cell Carcinoma+8 more
Emory University 29
Testing effectiveness (Phase 2)Study completedNCT00001048
What this trial is testing

Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected Patients

Who this might be right for
HIV InfectionsLeukoencephalopathy, Progressive Multifocal
National Institute of Allergy and Infectious Diseases (NIAID) 90
Testing effectiveness (Phase 2)Looking for participantsNCT07288073
What this trial is testing

TIL Therapy in cSCC and MCC

Who this might be right for
Cutaneous Squamous Cell CarcinomaMerkel Cell CarcinomaMetastatic Cutaneous Squamous Cell Carcinoma+1 more
Karam Khaddour, MD, MS 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT04869137
What this trial is testing

Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma

Who this might be right for
Merkel Cell CarcinomaNeuroendocrine Carcinoma of the SkinTrabecular Carcinoma of the Skin
H. Lee Moffitt Cancer Center and Research Institute 26
Testing effectiveness (Phase 2)Study completedNCT00002395
What this trial is testing

Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML)

Who this might be right for
HIV InfectionsLeukoencephalopathy, Progressive Multifocal
SmithKline Beecham 54
Testing effectiveness (Phase 2)Ended earlyNCT02036476
What this trial is testing

Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma

Who this might be right for
Merkel Cell CarcinomaSkin Cancer
Dana-Farber Cancer Institute 8
Not applicableUnknownNCT05224583
What this trial is testing

Prevalence of BK Viremia in Simultaneous Liver-Kidney Transplant

Who this might be right for
Polyomavirus InfectionsBK ViremiaLiver Transplant Infection+1 more
Methodist Health System 50
Early research (Phase 1)Study completedNCT03798639
What this trial is testing

Nivolumab and Radiation Therapy or Ipilimumab as Adjuvant Therapy in Treating Patients With Merkel Cell Cancer

Who this might be right for
Merkel Cell CarcinomaPathologic Stage IIIA Merkel Cell Carcinoma AJCC v8Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8
Claire Verschraegen 7
Testing effectiveness (Phase 2)Study completedNCT02267603
What this trial is testing

Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer

Who this might be right for
Recurrent Merkel Cell CarcinomaStage III Merkel Cell Carcinoma AJCC v7Stage IIIA Merkel Cell Carcinoma AJCC v7+2 more
National Cancer Institute (NCI) 50
Very early researchActive Not RecruitingNCT05358938
What this trial is testing

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Who this might be right for
Cutaneous MelanomaCutaneous Squamous Cell CarcinomaMerkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 22
Testing effectiveness (Phase 2)Looking for participantsNCT05267626
What this trial is testing

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
Advanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more
Aulos Bioscience, Inc. 159
Testing effectiveness (Phase 2)Ended earlyNCT03853317
What this trial is testing

QUILT-3.063: A Study of N-803, haNK and Avelumab in Patients With Merkel Cell Carcinoma That Has Progressed After Checkpoint Therapy

Who this might be right for
Merkel Cell Carcinoma
ImmunityBio, Inc. 9
Large-scale testing (Phase 3)Study completedNCT03783078
What this trial is testing

Pembrolizumab (MK-3475) as First-line Therapy for Advanced Merkel Cell Carcinoma (MK-3475-913)

Who this might be right for
Merkel Cell Carcinoma
Merck Sharp & Dohme LLC 55
Early research (Phase 1)Study completedNCT03652077
What this trial is testing

A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies

Who this might be right for
Cervical CancerGastric CancerStomach Cancer+18 more
Incyte Corporation 40
Load More Results